Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 2 Interventional

Phase II, Randomized, Placebo-Controlled Study of ATI-7505 in Patients With Chronic Idiopathic Constipation

ClinicalTrials.gov ID: NCT00501241

Public ClinicalTrials.gov record NCT00501241. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 8:32 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase II, Randomized, Placebo-Controlled Study of ATI-7505 in Patients With Chronic Idiopathic Constipation

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to determine whether ATI-7505 is effective in the treatment of chronic idiopathic constipation.

Study identification

NCT ID
NCT00501241
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 2
Lead sponsor
Procter and Gamble
Industry
Enrollment
214 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 2007 (Type not available)
Primary completion
Jul 2008 (Actual)
Completion
Jul 2008 (Actual)
Last update posted
Jun 17, 2009

2007 – 2008

United States locations

U.S. sites
20
U.S. states
13
U.S. cities
20
Facility City State ZIP Site status
Research Facility Anaheim California — —
Research facility San Carlos California — —
Research Facility San Diego California — —
Research Facility Littleton Colorado — —
Research Facility Aventura Florida — —
Research Facility Hollywood Florida — —
Research Facility South Miami Florida — —
Researrch Facility Newnan Georgia — —
Research Facility Rockford Illinois — —
Research Facility Evansville Indiana — —
Research Facility Boston Massachusetts — —
Research Facility Great Neck New York — —
Research Facility Lake Success New York — —
Research Facility Cincinnati Ohio — —
Research Facility Oklahoma City Oklahoma — —
Research Facility Chattanooga Tennessee — —
Research Facility Nashville Tennessee — —
Research Facility Salt Lake City Utah — —
Research Facility Charlottesville Virginia — —
Research Facility Christiansburg Virginia — —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 3 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00501241, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 17, 2009 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00501241 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →